MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 1 filers reported holding MERUS N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,891,639 | +222.8% | 122,631 | +260.4% | 1.34% | +226.3% |
| Q2 2023 | $895,931 | +6.0% | 34,027 | -26.0% | 0.41% | -40.5% |
| Q1 2023 | $845,609 | +14.1% | 45,957 | +24.2% | 0.69% | +62.9% |
| Q3 2022 | $741,000 | -19.1% | 36,994 | -8.6% | 0.42% | -23.5% |
| Q2 2022 | $916,000 | +14.1% | 40,481 | +33.2% | 0.55% | +8.2% |
| Q1 2022 | $803,000 | -53.1% | 30,388 | -43.6% | 0.51% | -62.5% |
| Q4 2021 | $1,712,000 | – | 53,840 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $32,048,000 | 13.34% |
| Lynx1 Capital Management LP | 613,071 | $12,280,000 | 11.08% |
| Aquilo Capital Management, LLC | 1,507,109 | $30,187,000 | 10.88% |
| COMMODORE CAPITAL LP | 2,615,762 | $52,394,000 | 8.42% |
| MPM BioImpact LLC | 918,310 | $18,394,000 | 4.36% |
| BVF INC/IL | 3,444,420 | $68,992,000 | 2.85% |
| Boxer Capital, LLC | 1,900,000 | $38,057,000 | 2.14% |
| Opaleye Management Inc. | 253,200 | $5,072,000 | 2.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,136 | $5,912,000 | 2.00% |
| TCG Crossover Management, LLC | 300,000 | $6,009,000 | 1.80% |